| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1999PNAS...96.8721S |
| P356 | DOI | 10.1073/PNAS.96.15.8721 |
| P932 | PMC publication ID | 17583 |
| P698 | PubMed publication ID | 10411942 |
| P5875 | ResearchGate publication ID | 235611756 |
| P2093 | author name string | M Nakamura | |
| E Neugebauer | |||
| J Q Trojanowski | |||
| M W Marino | |||
| R Raghupathi | |||
| T K McIntosh | |||
| K E Saatman | |||
| U Scherbel | |||
| P2860 | cites work | Cytokines and the nervous system II: Actions and mechanisms of action | Q28301619 |
| Characterization of tumor necrosis factor-deficient mice | Q28512785 | ||
| Tumor necrosis factor induces genes involved in inflammation, cellular and tissue repair, and metabolism in murine fibroblasts | Q33219595 | ||
| Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. | Q33900383 | ||
| TNF-α increases the frequency of spontaneous miniature synaptic currents in cultured rat hippocampal neurons | Q61052233 | ||
| Cytokine regulation of astrocyte function: in-vitro studies using cells from the human brain | Q61824997 | ||
| Peripheral blood mononuclear cells induce programmed cell death in human endothelial cells and may prevent repair: role of cytokines | Q61893861 | ||
| Accumulation of calcium in the brain following head trauma | Q69376582 | ||
| Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes | Q70359960 | ||
| Brain injury and tumor necrosis factors induce calbindin D-28k in astrocytes: evidence for a cytoprotective response | Q70956389 | ||
| Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors | Q71169977 | ||
| Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window | Q71289958 | ||
| Temporal and spatial characterization of neuronal injury following lateral fluid-percussion brain injury in the rat | Q71600063 | ||
| Tumor necrosis factor promotes motor functional recovery in crushed peripheral nerve | Q71605884 | ||
| Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of Lewis rats with myelin basic protein | Q71682272 | ||
| Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures | Q72130001 | ||
| The presence of tumour necrosis factor in CSF and plasma after severe head injury | Q72384761 | ||
| Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis | Q72458408 | ||
| Apoptotic morphology of dentate gyrus granule cells following experimental cortical impact injury in rats: possible role in spatial memory deficits | Q34410540 | ||
| Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS. | Q34411050 | ||
| Protective roles of cytokines against radiation: induction of mitochondrial MnSOD. | Q34720398 | ||
| Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. | Q36377414 | ||
| Structural changes of tumor necrosis factor alpha associated with membrane insertion and channel formation | Q37728008 | ||
| Cytokines in neurodegeneration and repair | Q40420561 | ||
| Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. | Q40606762 | ||
| Down-regulation of cytokine action | Q40676140 | ||
| Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli | Q41082615 | ||
| The role of inflammation and cytokines in brain injury | Q41176104 | ||
| An endogenous 55 kDa TNF receptor mediates cell death in a neural cell line. | Q41194213 | ||
| Toxicity of TNF alpha and platelet activating factor for human NT2N neurons: a tissue culture model for human immunodeficiency virus dementia | Q41207855 | ||
| TNF and related molecules: trends in neuroscience and clinical applications | Q41355384 | ||
| Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant | Q41355460 | ||
| Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome | Q41622822 | ||
| Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand | Q42509804 | ||
| Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice | Q42526145 | ||
| Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. | Q42789395 | ||
| Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non-neuronal cells. | Q42811916 | ||
| Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor | Q42943618 | ||
| The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. | Q43843852 | ||
| A controlled cortical impact model of traumatic brain injury in the rat | Q44932406 | ||
| The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury | Q45086104 | ||
| Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice. | Q45977817 | ||
| Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury | Q46080372 | ||
| Histological and functional evaluation of experimental spinal cord injury: evidence of a stepwise response to graded compression | Q46686008 | ||
| Formation of ion-permeable channels by tumor necrosis factor-alpha | Q46717063 | ||
| Neutrophil accumulation after traumatic brain injury in rats: comparison of weight drop and controlled cortical impact models | Q47368717 | ||
| Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period. | Q47812559 | ||
| Expression of mRNA, interleukin-1 beta, interleukin 6 and tumor necrosis factor-alpha during regeneration of the sciatic nerve in rats after tissue loss | Q48067202 | ||
| Tumor necrosis factor-alpha expression in ischemic neurons | Q48094066 | ||
| Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats | Q48113684 | ||
| Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease | Q48149523 | ||
| Persistent memory dysfunction is associated with bilateral hippocampal damage following experimental brain injury | Q48171929 | ||
| TNF alpha gene expression is induced in neurones after a hippocampal lesion. | Q48187813 | ||
| Localization of TNF alpha and IL-1 alpha immunoreactivities in striatal neurons after surgical injury to the hippocampus | Q48337926 | ||
| BCL-2 overexpression attenuates cortical cell loss after traumatic brain injury in transgenic mice | Q48354134 | ||
| Twofold overexpression of human beta-amyloid precursor proteins in transgenic mice does not affect the neuromotor, cognitive, or neurodegenerative sequelae following experimental brain injury | Q48503614 | ||
| Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury | Q48698077 | ||
| TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice | Q48714135 | ||
| Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue | Q48779728 | ||
| Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. | Q48887459 | ||
| Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide | Q48920499 | ||
| Calcium movements in traumatic brain injury: the role of glutamate receptor-operated ion channels | Q49108698 | ||
| Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. | Q50755877 | ||
| Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. | Q50891216 | ||
| A Model of Parasagittal Controlled Cortical Impact in the Mouse: Cognitive and Histopathologic Effects | Q52053625 | ||
| Evaluation of Memory Dysfunction Following Experimental Brain Injury Using the Morris Water Maze | Q52102934 | ||
| Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury. | Q52519393 | ||
| Concussive brain injury is associated with a prolonged accumulation of calcium: a 45Ca autoradiographic study. | Q52548250 | ||
| TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. | Q54150165 | ||
| Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. | Q54374888 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8721-8726 | |
| P577 | publication date | 1999-07-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury | |
| P478 | volume | 96 |
| Q34674936 | 2',3'-cAMP, 3'-AMP, 2'-AMP and adenosine inhibit TNF-α and CXCL10 production from activated primary murine microglia via A2A receptors. |
| Q96690858 | 3,6'-Dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation |
| Q93385498 | A Cerebrovascular Hypothesis of Neurodegeneration in mTBI |
| Q30950373 | A detrimental role for nitric oxide synthase-2 in the pathology resulting from acute cerebral injury |
| Q30479072 | A genetic model of chronic rhinosinusitis-associated olfactory inflammation reveals reversible functional impairment and dramatic neuroepithelial reorganization |
| Q34433733 | A review and rationale for the use of genetically engineered animals in the study of traumatic brain injury |
| Q44349927 | Activated/effector CD4+ T cells exacerbate acute damage in the central nervous system following traumatic injury |
| Q35050227 | An unliganded thyroid hormone receptor causes severe neurological dysfunction |
| Q41810562 | Animal models and biomarkers of neuropathy in diabetic rodents |
| Q47249683 | Association between tumor necrosis factor-alpha gene polymorphism and Sasang constitution in cerebral infarction. |
| Q28567214 | Astrocyte reactivity to unconjugated bilirubin requires TNF-α and IL-1β receptor signaling pathways |
| Q34243826 | CCL2 modulates cytokine production in cultured mouse astrocytes. |
| Q42229910 | Calpastatin overexpression limits calpain-mediated proteolysis and behavioral deficits following traumatic brain injury |
| Q74372203 | Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities |
| Q28383048 | Cerebrospinal Fluid Markers of Macrophage and Lymphocyte Activation After Traumatic Brain Injury in Children |
| Q26744281 | Chronic impact of traumatic brain injury on outcome and quality of life: a narrative review |
| Q24543977 | Clinical trials in head injury |
| Q47653416 | Commonalities in epileptogenic processes from different acute brain insults: Do they translate? |
| Q97516693 | Cosyntropin Attenuates Neuroinflammation in a Mouse Model of Traumatic Brain Injury |
| Q34671589 | Craniotomy: true sham for traumatic brain injury, or a sham of a sham? |
| Q34976390 | Critical mechanisms of secondary damage after inflicted head injury in infants and children |
| Q34806489 | Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury |
| Q52345148 | Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire? |
| Q37229166 | Cytokine gene polymorphisms and outcome after traumatic brain injury |
| Q28190084 | Cytokines and acute neurodegeneration |
| Q36902293 | Cytokines and neuronal ion channels in health and disease. |
| Q38012791 | Cytokines in schizophrenia: possible role of anti-inflammatory medications in clinical and preclinical stages |
| Q36240558 | Depletion of macrophages in CD11b diphtheria toxin receptor mice induces brain inflammation and enhances inflammatory signaling during traumatic brain injury. |
| Q92604850 | Dexmedetomidine reduces inflammation in traumatic brain injury by regulating the inflammatory responses of macrophages and splenocytes |
| Q36273698 | Do pathogen exposure and innate immunity cause brain diseases? |
| Q36112435 | Early intervention with a small molecule inhibitor for tumor necrosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's disease |
| Q47957399 | Effect of traumatic brain injury on cognitive function in mice lacking p55 and p75 tumor necrosis factor receptors. |
| Q36343103 | Effects of Etanercept against Transient Cerebral Ischemia in Diabetic Rats |
| Q89664849 | Effects of a solid lipid curcumin particle formulation on chronic activation of microglia and astroglia in the GFAP-IL6 mouse model |
| Q74339233 | Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury |
| Q52581482 | Elevation of MMP-9 Levels Promotes Epileptogenesis After Traumatic Brain Injury. |
| Q28071271 | Emerging Roles for the Immune System in Traumatic Brain Injury |
| Q38531165 | Emerging pharmacotherapy for treatment of traumatic brain injury: targeting hypopituitarism and inflammation. |
| Q28087789 | Emerging therapies in traumatic brain injury |
| Q36844981 | Etanercept attenuates traumatic brain injury in rats by reducing brain TNF- α contents and by stimulating newly formed neurogenesis |
| Q34621724 | Etanercept attenuates traumatic brain injury in rats by reducing early microglial expression of tumor necrosis factor-α |
| Q35014695 | Expression profiling following traumatic brain injury: a review |
| Q48130829 | FLIP(L) protects neurons against in vivo ischemia and in vitro glucose deprivation-induced cell death. |
| Q36966520 | Fractalkine Receptor Deficiency Is Associated with Early Protection but Late Worsening of Outcome following Brain Trauma in Mice |
| Q47415104 | Functional Genomic Analysis of Remyelination Reveals Importance of Inflammation in Oligodendrocyte Regeneration |
| Q34145724 | Genetic analysis of the role of tumor necrosis factor receptors in functional outcome after traumatic brain injury in mice |
| Q35201289 | Genetic programs and responses of neural stem/progenitor cells during demyelination: potential insights into repair mechanisms in multiple sclerosis |
| Q59273858 | Genetic variants in the tumor necrosis factor receptor II gene in patients with multiple sclerosis |
| Q48434896 | Guanosine Protects Against Traumatic Brain Injury-Induced Functional Impairments and Neuronal Loss by Modulating Excitotoxicity, Mitochondrial Dysfunction, and Inflammation. |
| Q36026673 | Guilty molecules, guilty minds? The conflicting roles of the innate immune response to traumatic brain injury |
| Q27023968 | HIV Associated Neurocognitive Disorders |
| Q90049912 | Heat-Shock Proteins in Neuroinflammation |
| Q42053546 | Hemorrhagic shock shifts the serum cytokine profile from pro- to anti-inflammatory after experimental traumatic brain injury in mice |
| Q37832963 | Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries |
| Q34196336 | Hyperthermia following traumatic brain injury: a critical evaluation |
| Q38421081 | Improved fracture healing in patients with concomitant traumatic brain injury: proven or not? |
| Q46644991 | Increased infarct size and lack of hyperphagic response after focal cerebral ischemia in peroxisome proliferator-activated receptor beta-deficient mice |
| Q92513493 | Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury |
| Q37586600 | Inflammation in epileptogenesis after traumatic brain injury. |
| Q34405662 | Influence of age on brain edema formation, secondary brain damage and inflammatory response after brain trauma in mice |
| Q36992077 | Integration of cytokine biology and lipid metabolism in stroke |
| Q88696079 | Interleukin-1 Receptor 1 Deletion in Focal and Diffuse Experimental Traumatic Brain Injury in Mice |
| Q48509941 | Interleukin-1beta messenger ribonucleic acid and protein levels after fluid-percussion brain injury in rats: importance of injury severity and brain temperature |
| Q34749274 | Involvement of inflammatory cytokines in central nervous system injury |
| Q37686762 | Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury |
| Q46911576 | Involvement of the AMPA receptor GluR-C subunit in alcohol-seeking behavior and relapse. |
| Q35554376 | Lateral fluid percussion: model of traumatic brain injury in mice |
| Q33657758 | Magnetic resonance imaging assessment of macrophage accumulation in mouse brain after experimental traumatic brain injury |
| Q48638931 | Mild traumatic brain injury induces apoptotic cell death in the cortex that is preceded by decreases in cellular Bcl-2 immunoreactivity |
| Q36276090 | Modulation of the cAMP signaling pathway after traumatic brain injury. |
| Q46610667 | Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. |
| Q37286638 | Molecular and cellular basis of epileptogenesis in symptomatic epilepsy |
| Q41995595 | NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats |
| Q38188728 | Nervous and immune systems signals and connections: cytokines in hippocampus physiology and pathology. |
| Q28069959 | Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation |
| Q48113339 | Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift |
| Q92191065 | Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments |
| Q37546147 | Neuroinflammation in animal models of traumatic brain injury |
| Q38072367 | Neuroinflammation: beneficial and detrimental effects after traumatic brain injury |
| Q35217964 | Neuronal deletion of caspase 8 protects against brain injury in mouse models of controlled cortical impact and kainic acid-induced excitotoxicity |
| Q26824808 | Neuroprotection for traumatic brain injury |
| Q33587711 | Neuroprotective pentapeptide CN-105 is associated with reduced sterile inflammation and improved functional outcomes in a traumatic brain injury murine model |
| Q36402221 | Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease |
| Q40526881 | Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. |
| Q88528016 | Phosphodiesterase 4 and 7 inhibitors produce protective effects against high glucose-induced neurotoxicity in PC12 cells via modulation of the oxidative stress, apoptosis and inflammation pathways |
| Q38908062 | Plasticity in respiratory motor neurons in response to reduced synaptic inputs: A form of homeostatic plasticity in respiratory control? |
| Q37045248 | Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat. |
| Q35549686 | Post-traumatic hypoxia exacerbates neurological deficit, neuroinflammation and cerebral metabolism in rats with diffuse traumatic brain injury |
| Q36664950 | Principal components derived from CSF inflammatory profiles predict outcome in survivors after severe traumatic brain injury |
| Q44723151 | Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. |
| Q40383266 | Rapid neuroinflammatory response localized to injured neurons after diffuse traumatic brain injury in swine |
| Q35556472 | Rate of neurodegeneration in the mouse controlled cortical impact model is influenced by impactor tip shape: implications for mechanistic and therapeutic studies |
| Q57460363 | Regenerative Strategies for the Central Nervous System |
| Q39250156 | Regional TNFα mapping in the brain reveals the striatum as a neuroinflammatory target after ventricular fibrillation cardiac arrest in rats. |
| Q53246017 | Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. |
| Q33600522 | Reversible loss of neuronal marker protein expression in a transgenic mouse model for sinusitis-associated olfactory dysfunction |
| Q28268523 | Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice |
| Q34168279 | Role of microglia in neurotrauma |
| Q48415776 | Selective increase in TNF alpha permeation across the blood-spinal cord barrier after SCI. |
| Q74347094 | Soluble TNF receptors partially protect injured motoneurons in the postnatal CNS |
| Q48218630 | TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice |
| Q33181856 | TNF-alpha stimulates caspase-3 activation and apoptotic cell death in primary septo-hippocampal cultures. |
| Q36330960 | Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases |
| Q52971297 | Temporal profile of cerebrospinal fluid glutamate, interleukin-6, and tumor necrosis factor-alpha in relation to brain edema and contusion following controlled cortical impact injury in rats. |
| Q34520132 | The duality of the inflammatory response to traumatic brain injury |
| Q53600926 | The effect of thalidomide on spinal cord ischemia/reperfusion injury in a rabbit model. |
| Q30235977 | The far-reaching scope of neuroinflammation after traumatic brain injury |
| Q35981187 | The neuroprotective role of inflammation in nervous system injuries. |
| Q28397332 | The potential for bio-mediators and biomarkers in pediatric traumatic brain injury and neurocritical care |
| Q36364424 | The role of inflammation in CNS injury and disease |
| Q38086443 | The role of markers of inflammation in traumatic brain injury. |
| Q42876676 | The role of the purinergic P2X7 receptor in inflammation |
| Q38029928 | Therapeutic hypothermia for traumatic brain injury |
| Q36925788 | Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies |
| Q35102824 | To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways |
| Q36898647 | Toll-like receptors in the brain and their potential roles in neuropathology. |
| Q36731657 | Transient blockage of the CD11d/CD18 integrin reduces contusion volume and macrophage infiltration after traumatic brain injury in rats |
| Q35155498 | Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice |
| Q40703966 | Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury |
| Q49143989 | Traumatic Brain Injury Increases the Expression of Nos1, Aβ Clearance, and Epileptogenesis in APP/PS1 Mouse Model of Alzheimer's Disease. |
| Q37652612 | Traumatic brain injury and aeromedical evacuation: when is the brain fit to fly? |
| Q35171581 | Traumatic brain injury in infants and children: mechanisms of secondary damage and treatment in the intensive care unit |
| Q36428733 | Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets |
| Q42653063 | Tumor necrosis factor alpha and Fas receptor contribute to cognitive deficits independent of cell death after concussive traumatic brain injury in mice |
| Q54708947 | Tumor necrosis factor alpha expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature. |
| Q42445258 | Tumor necrosis factor alpha increases cytosolic calcium responses to AMPA and KCl in primary cultures of rat hippocampal neurons |
| Q37036628 | Tumor necrosis factor alpha is reparative via TNFR2 [corrected] in the hippocampus and via TNFR1 [corrected] in the striatum after virus-induced encephalitis |
| Q37073380 | Tumor necrosis factor in traumatic brain injury: effects of genetic deletion of p55 or p75 receptor |
| Q74411614 | Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury |
| Q34390682 | Tumor necrosis factor(alpha) and insulin-like growth factor-I in the brain: is the whole greater than the sum of its parts? |
| Q24797164 | Tumor necrosis factor-mediated inhibition of interleukin-18 in the brain: a clinical and experimental study in head-injured patients and in a murine model of closed head injury |
| Q30520539 | Tumor necrosis factor-α synthesis inhibitor, 3,6'-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice |
| Q48210297 | Two effective behavioral tasks for evaluating sensorimotor dysfunction following traumatic brain injury in mice |
| Q31149457 | Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma |
| Q38068175 | Understanding the neuroinflammatory response following concussion to develop treatment strategies |
| Q34266387 | Unravelling the pathophysiology of heart failure through human genomics |
| Q42163696 | Varied actions of proinflammatory cytokines on excitotoxic cell death in the rat central nervous system |
| Q73770795 | Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway |
| Q79858416 | [The relevance of the inflammatory response in the injured brain] |
Search more.